Your new experience awaits. Try the new design now and help us make it even better

REVIEW article

Front. Artif. Intell.

Sec. Medicine and Public Health

Volume 8 - 2025 | doi: 10.3389/frai.2025.1668794

AI alignment is all your need for future drug discovery

Provisionally accepted
  • Yunnan Normal University, Kunming, China

The final, formatted version of the article will be published soon.

In recent years, the integration of artificial intelligence (AI) with drug discovery has become a promising frontier in biomedical research. However, as artificial intelligence systems become increasingly complex, ensuring their alignment with human values and goals becomes essential. Specifically, combining artificial intelligence systems with human values is crucial for reducing potential risks in the field of drug discovery and maximizing social benefits. This article explores the concepts and challenges related to alignment with artificial intelligence in the context of drug discovery, emphasizing on human-centered approaches to AI development and deployment. We further investigated popular technology frameworks designed for human-centered AI alignment, aimed at improving the robustness and interpretability of AI models. We provide some insights into the challenges of human-centered AI alignment, which represents a significant advancement in addressing robustness and interpretability, thus taking a step forward in the field of AI alignment research. Finally, we discuss strategies for systematically integrating human values into AI-driven drug discovery systems. This article aims to emphasize the importance of AI alignment as a foundational principle in the field of drug discovery and advocate the perspective that "AI alignment is all your need for future drug discovery".

Keywords: AI alignment, Drug Discovery, Human Values, Generative AI, robustness, Interpretability

Received: 18 Jul 2025; Accepted: 13 Oct 2025.

Copyright: © 2025 Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Chunyan Li, lchy@ynnu.edu.cn

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.